CN101972444A - Traditional Chinese medicine composition for treating mastitis and preparation method thereof - Google Patents

Traditional Chinese medicine composition for treating mastitis and preparation method thereof Download PDF

Info

Publication number
CN101972444A
CN101972444A CN2010102249665A CN201010224966A CN101972444A CN 101972444 A CN101972444 A CN 101972444A CN 2010102249665 A CN2010102249665 A CN 2010102249665A CN 201010224966 A CN201010224966 A CN 201010224966A CN 101972444 A CN101972444 A CN 101972444A
Authority
CN
China
Prior art keywords
parts
radix
rhizoma
chinese medicine
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010102249665A
Other languages
Chinese (zh)
Inventor
王峰
王文奎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Original Assignee
Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd filed Critical Taiyi Hepu Beijing Research Institute of Traditional Chinese Medicine Co Ltd
Priority to CN2010102249665A priority Critical patent/CN101972444A/en
Publication of CN101972444A publication Critical patent/CN101972444A/en
Pending legal-status Critical Current

Links

Abstract

The invention discloses a new traditional Chinese medicine composition for treating mastitis and a preparation method thereof. The traditional Chinese medicine composition mainly comprises the following raw material drugs: Kushen, figwort root, honeysuckle, forsythia, dandelion, Chinese violet, rhizome of chuanxiong, dried tangerine, immature bitter orange, costus root, curcuma aromatica, manis pentadactyla, root of red-rooted salvia, peach kernel, red flower, agilawood, Cyperus rotundus, lindera aggregata, aspongopus, cogongrass rhizome, garden burnet, Carcuma longa, leonurus, and the like. The traditional Chinese medicine composition can be prepared into any common oral preparation by the conventional traditional Chinese medicine preparation method. The traditional Chinese medicine composition can obviously improve the symptoms of breast swelling and pains, bossing tenderness, surface red and swollen, fevering, even breast fluctuant pain and the like, and has the advantages of exact clinical effect, obvious curative effect, rapid effect taking, low cost, no toxic or side effect and the like.

Description

A kind of Chinese medicine composition for the treatment of mastitis and preparation method thereof
?
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of mastitis.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment mastitis of crude drug with the Chinese herbal medicine.
 
Background technology
Mastitis are meant that the acute festering type of mammary gland infects, and are the puerperal commonly encountered diseases, are one of reasons that causes puerperal fever, are most commonly in the nursing women, especially the primipara.Any time of age of sucking all can take place, and the beginning of suckling is the most common.The harm of mastitis is bigger, first time-out mammary swelling, pain, and the lump tenderness, the surface is red and swollen, heating; As continue development, sx then, breast undulatory property pain.Though the probability of this disease canceration is low, has a strong impact on Health and Living, the clinical onset rate has the trend of continuous rising in recent years.
Modern medicine is at clinical a certain symptom treatment, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment mastitis, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out the natural plant of promoting flow of QI and blood, heat-clearing and toxic substances removing, soothing the channels and quicking the network vessels,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment mastitis that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
 
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment mastitis of evident in efficacy, with low cost, almost non-toxic side effect is provided.
Technical problem to be solved by this invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of mastitis of the present invention, the component of main following weight portion is formed:
1~120 part of Radix Sophorae Flavescentis, 1~120 part of Radix Scrophulariae, 1~100 part of Flos Lonicerae, 1~100 part of Fructus Forsythiae, 1~100 part of Herba Taraxaci, 1~100 part of Herba Violae, 1~120 part of Rhizoma Chuanxiong, 1~150 part of Pericarpium Citri Reticulatae, 1~120 part of Fructus Aurantii Immaturus, 1~120 part of Radix Aucklandiae (Radix Vladimiriae), 1~100 part of Radix Curcumae, 1~50 part of Squama Manis, 1~50 part of Carapax Trionycis (processed), 1~50 part of Carapax Et Plastrum Testudinis (processed), 1~120 part of Radix Rehmanniae, 1~120 part of the Radix Paeoniae Alba, 1~100 part of Radix Paeoniae Rubra, 1~100 part of Radix Salviae Miltiorrhizae, 1~50 part in Semen Persicae, 1~50 part on Flos Carthami, 1~100 part of Lignum Aquilariae Resinatum, 1~120 part of Rhizoma Cyperi, 1~120 part of the Radix Linderae, 1~150 part of Fructus Toosendan, 1~100 part of Aspongopus, 1~100 part of Massa Medicata Fermentata, 1~50 part of Fructus Crataegi (parched to brown), 1~120 part of Rhizoma Imperatae, 1~100 part of Radix Sanguisorbae.
Be preferably:
30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1~120 part in Rhizoma Curcumae Longae, 1~50 part of Olibanum (processed), 1~50 part of Myrrha (processed), 1~150 part of Herba Leonuri, 1~100 part of Flos Rosae Chinensis, 1~50 part of Sanguis Draxonis, 1~50 part of rhizoma sparganic, 1~50 part of Rhizoma Curcumae, 1~120 part of Radix Astragali, 1~100 part of Rhizoma Dioscoreae, 1~100 part of Cortex Lycii, 1~100 part of Radix Stellariae, 1~100 part of Rhizoma Picrorhizae, 1~100 part of Radix Et Rhizoma Rhei, 1~120 part of Cortex Moutan, 1~120 part of Radix Arnebiae (Radix Lithospermi), 1~100 part of Radix Trichosanthis.
Be preferably:
30 parts in Rhizoma Curcumae Longae, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 50 parts of Herba Leonuris, 20 parts of Flos Rosae Chinensiss, 15 parts of Sanguis Draxonis, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Astragali, 30 parts of Rhizoma Dioscoreaes, 20 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Cortex Moutans, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Trichosanthis.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2~5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The treatment that the present invention is directed to the mastitis patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
 
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material by following weight portion: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800~1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material by following weight portion: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
Each raw material of above-mentioned weight is mixed, grind into cross 600~1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material by following weight portion: 30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into
Normal concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
 
[experimental example] traditional Chinese medicine composition for treating mastitis of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 115 routine patients altogether, wherein male 0 example, women 115 examples; The oldest person 46 years old, the age reckling has only 17 years old.
 
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2~5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2~4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 5 grams, warm water takes.4) granule: every day three times.Each 5 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 5 courses of treatment altogether.
 
Three, therapeutic evaluation standard
Cure: sign and symptom are improved fully, and swelling of the breast, lump in breast disappear, and be happy, in high spirits.
Produce effects: sign and symptom are significantly improved, and swelling of the breast, lump in breast disappear substantially, and be happy, and spirit is fine.
Effectively: sign and symptom change, and swelling of the breast, lump in breast have discomfort slightly, but can accept.
Invalid: sign does not have change, symptom such as preceding.
 
Four, model case:
1, Zhang, woman, 24 years old.
Main suit: 17 days puerperal, bilateral breast swell and pain companion hyperpyrexia 2 days.Before the patient two days, conscious two distending pain of the breast have lump, touch a tender spot obviously.Massage, hot compress voluntarily, symptom does not subtract.Back hyperpyrexia swells and ache and increases the weight of to go to a doctor.Check: go up outer going up between the quadrant in the bilateral breast and respectively lay one's hand on and 4 * 5 centimetres of lumps, matter is hard, sharpness of border, and tenderness is obvious, and local flushing is scorching hot, calm innervation.39.7 ℃ of body temperature.Red tongue, yellow fur is thick, full and rapid pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 1 month, the right breast lump disappears, and the left side lump is contracted to 1.5 * 2 centimetres, and deliquescing, pain relief, and body temperature is reduced to normally (36.7 ℃).Continue and obeyed Chinese medicine composition of the present invention 2 months, the also complete obiteration of left breast lump, all diseases are flat, patient's recovery from illness.
2, the king so-and-so, woman, 25 years old.
The main suit: in 2 months puerperal, right breast swell and pain occurred together hot 2 days in 3 days.Latter two month produced in patient's primiparity, and lochia is clean.Right mammary swelling, bitterly, milk drainage difficulty 3 days has played symptoms such as heating (38.2 ℃ of body temperature), headache evening before that day, examines over second day.Check: right breast is outer goes up the quadrant caking obviously, and owe clearly on the border, tenderness, and Pi Wenlvegao, color of the leather is little red.Yellow and thin fur, red tongue, wiry and frequent pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 15, heating is disappeared, and body temperature is reduced to normally (36.5 ℃), and the place breast is discharged.Continue and obeyed Chinese medicine composition of the present invention 2 months, caking fades away, and breast is soft, and all diseases are flat, patient's recovery from illness.
3, Zhao so-and-so, woman, 28 years old.
Main suit: 3 months puerperal, right breast caking 5 weeks of pain.Patient's primiparity, in three months puerperal, right breast caking pain is 5 weeks.The outer top of the conscious right breast of patient distending pain does not add attention before 5 weeks during beginning, and caking after 5 days, pain are obvious, and for oral administration through intravenous drip penicillin and heat-clearing and detoxifying herb with heating, though suppurate, caking does not still disappear.Check: there are about 3 * 3 centimetres of lumps the outer top of right breast, and it is stiff to lump, and that presses slightly feels pain, calm innervation, and color of the leather is not red.The little Huang of greasy and thin fur, light red tongue, stringy pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 10, the pain of pressing is not obvious.Continue and obeyed Chinese medicine composition of the present invention 7, right breast caking reduces gradually.Continue and obeyed Chinese medicine composition of the present invention 2 months, the caking complete obiteration, the no pain of pressing, all diseases are flat, patient's recovery from illness.
4, the gold so-and-so, woman, 26 years old.
Main suit: 5 months puerperal, 1 week of lump in breast pain.Little lump is found on patient's early discovery breast top, does not have pain at that time, conscious no uncomfortable symptom.Before the about week, sensation lump position pain, skin is not rubescent, does not have heating.The affected part was applied two days with plaster in the back, and the plaster composition is not quite clear.Next generate heat twice, body temperature all more than 39 °, is brought down a fever with the pin of bringing down a fever, and oral anti-inflammatory drug.Check: the lump redness, that presses should refer to, peripheral pain.Red tongue, yellow fur, wiry and frequent pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 15, lump dwindles, the conscious pain relief of patient.Continue and obeyed Chinese medicine composition of the present invention 15, lump in breast fades away, heating again during the treatment.The clothes Chinese medicine composition of the present invention that continues was consolidated 3 months, and all diseases are flat, patient's recovery from illness.
5, fourth, woman, 29 years old.
Main suit: 40 days puerperal, lump in breast 20 days.20 days puerperal of patient, conscious breast had lump, did not keenly feel at that time, did not give processing.The back finds that breast milk reduces, and lump position congestion and swelling pain, heating.Through hospital's infusion treatment one Zhou Houwei commentaries on classics of getting better, lump position emersion wave innervation, the position is higher than skin surface.Check: the lump tenderness, the surface is red and swollen, heating.Red tongue, yellow and thin fur, rapid pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 5, pain relief is disappeared in lump position redness, heating.The clothes Chinese medicine composition of the present invention 15 days that continues, lump in breast diminishes gradually, and that presses slightly feels pain.Continue and obeyed Chinese medicine composition of the present invention 3 months, lump disappears, and does not have pain, and all diseases are flat, patient's recovery from illness.
6, Zou, woman, 23 years old.
The main suit: in 10 days puerperal, mammary swelling has lump.Ten days puerperal of patient, the milk abundance, because the fair ability of baby's suction, and the stomach volume is limited, makes breast emptying in time.The breast overflow, milk is from overflowing.Touch breast, side has lump to occur, and that touches has a pain.Check: there is lump the breast both sides, and skin is not red, tenderness.The tongue fur BOHUANG, wiry and frequent pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 3, the lump in breast deliquescing that obviously diminishes, pain relief.Continue and obeyed Chinese medicine composition of the present invention 10, the affected part lump dissipates, does not have pain, and milk is drained smooth and easy.Continue and obeyed Chinese medicine composition of the present invention 2 months, all diseases are flat, patient's recovery from illness.
7, Xu so-and-so, woman, 26 years old.
The main suit: in 23 days puerperal, left breast swelled and ache 4 days.The patient over 4 days left breast swell and ache, the milk drainage difficulty has lump by it, headache is not uncomfortable in chestly relaxed, body temperature is normal.Check: the lump in breast distending pain, skin is little red.Red tongue, yellow and thin fur, wiry and frequent pulse.Examine and be mastitis.
Took Chinese medicine composition of the present invention 5, the lump in breast distending pain is alleviated, and skin is not red.Continue and obeyed Chinese medicine composition of the present invention 5, the left breast lump disappears, and milk is unobstructed.Continue and obey 1 first quarter moon of Chinese medicine composition of the present invention, no any discomfort sense, the sick announcement fully recovered.
 
Five, therapeutic outcome:
In the 115 routine cases of being accepted for medical treatment,, wherein cure 54 examples through treatment in 5 months, produce effects 39 examples, effective 20 examples, invalid 2 examples, total effective rate reaches 98 %.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment mastitis patient.

Claims (7)

1. Chinese medicine composition for the treatment of mastitis is characterized in that: mainly contain following bulk drugs and form:
1~120 part of Radix Sophorae Flavescentis, 1~120 part of Radix Scrophulariae, 1~100 part of Flos Lonicerae, 1~100 part of Fructus Forsythiae, 1~100 part of Herba Taraxaci, 1~100 part of Herba Violae, 1~120 part of Rhizoma Chuanxiong, 1~150 part of Pericarpium Citri Reticulatae, 1~120 part of Fructus Aurantii Immaturus, 1~120 part of Radix Aucklandiae (Radix Vladimiriae), 1~100 part of Radix Curcumae, 1~50 part of Squama Manis, 1~50 part of Carapax Trionycis (processed), 1~50 part of Carapax Et Plastrum Testudinis (processed), 1~120 part of Radix Rehmanniae, 1~120 part of the Radix Paeoniae Alba, 1~100 part of Radix Paeoniae Rubra, 1~100 part of Radix Salviae Miltiorrhizae, 1~50 part in Semen Persicae, 1~50 part on Flos Carthami, 1~100 part of Lignum Aquilariae Resinatum, 1~120 part of Rhizoma Cyperi, 1~120 part of the Radix Linderae, 1~150 part of Fructus Toosendan, 1~100 part of Aspongopus, 1~100 part of Massa Medicata Fermentata, 1~50 part of Fructus Crataegi (parched to brown), 1~120 part of Rhizoma Imperatae, 1~100 part of Radix Sanguisorbae.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts of Radix Sophorae Flavescentiss, 30 parts of Radix Scrophulariaes, 30 parts of Flos Loniceraes, 20 parts of Fructus Forsythiaes, 20 parts of Herba Taraxacis, 20 parts of Herba Violaes, 30 parts of Rhizoma Chuanxiongs, 100 parts of Pericarpium Citri Reticulataes, 30 parts of Fructus Aurantii Immaturuss, 20 parts of Radix Aucklandiae (Radix Vladimiriae), 20 parts of Radix Curcumaes, 15 parts of Squama Maniss, 15 parts of Carapax Trionycis (processed), 15 parts of Carapax Et Plastrum Testudinis (processed), 20 parts of Radix Rehmanniae, 30 parts of the Radix Paeoniae Albas, 20 parts of Radix Paeoniae Rubra, 20 parts of Radix Salviae Miltiorrhizaes, 15 parts in Semen Persicae, 15 parts on Flos Carthami, 20 parts of Lignum Aquilariae Resinatum, 30 parts of Rhizoma Cyperi, 30 parts of the Radixs Linderae, 50 parts of Fructus Toosendans, 20 parts of Aspongopuss, 20 parts of Massa Medicata Fermentata, 15 parts of Fructus Crataegi (parched to brown)s, 30 parts of Rhizoma Imperataes, 20 parts of Radix Sanguisorbaes.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1~120 part in Rhizoma Curcumae Longae, 1~50 part of Olibanum (processed), 1~50 part of Myrrha (processed), 1~150 part of Herba Leonuri, 1~100 part of Flos Rosae Chinensis, 1~50 part of Sanguis Draxonis, 1~50 part of rhizoma sparganic, 1~50 part of Rhizoma Curcumae, 1~120 part of Radix Astragali, 1~100 part of Rhizoma Dioscoreae, 1~100 part of Cortex Lycii, 1~100 part of Radix Stellariae, 1~100 part of Rhizoma Picrorhizae, 1~100 part of Radix Et Rhizoma Rhei, 1~120 part of Cortex Moutan, 1~120 part of Radix Arnebiae (Radix Lithospermi), 1~100 part of Radix Trichosanthis.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
30 parts in Rhizoma Curcumae Longae, 15 parts of Olibanum (processed), 15 parts of Myrrha (processed)s, 50 parts of Herba Leonuris, 20 parts of Flos Rosae Chinensiss, 15 parts of Sanguis Draxonis, 15 parts of rhizoma sparganic, 15 parts of Rhizoma Curcumae, 30 parts of Radix Astragali, 30 parts of Rhizoma Dioscoreaes, 20 parts of Cortex Lycii, 20 parts of Radix Stellariaes, 20 parts of Rhizoma Picrorhizae, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Cortex Moutans, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Radix Trichosanthis.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1~6 in preparation treatment mastitis medicine.
CN2010102249665A 2010-07-13 2010-07-13 Traditional Chinese medicine composition for treating mastitis and preparation method thereof Pending CN101972444A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102249665A CN101972444A (en) 2010-07-13 2010-07-13 Traditional Chinese medicine composition for treating mastitis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102249665A CN101972444A (en) 2010-07-13 2010-07-13 Traditional Chinese medicine composition for treating mastitis and preparation method thereof

Publications (1)

Publication Number Publication Date
CN101972444A true CN101972444A (en) 2011-02-16

Family

ID=43572377

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102249665A Pending CN101972444A (en) 2010-07-13 2010-07-13 Traditional Chinese medicine composition for treating mastitis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101972444A (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670793A (en) * 2012-05-04 2012-09-19 山西华诚睿光生物科技有限公司 Chinese herba preparation for increasing cow immunity and reducing milk somatic number and preparation method
CN102973923A (en) * 2012-12-19 2013-03-20 上海光明荷斯坦牧业有限公司 Compound premix for preventing and treating dairy cow mastitis recessive, and preparation method and application
CN103041363A (en) * 2013-01-21 2013-04-17 孔云 Medicament for treating mammitis
CN103191370A (en) * 2013-04-10 2013-07-10 成都中医药大学 Medicine composite for treating mastitis and preparation method and application of medicine composite
CN103356802A (en) * 2013-07-26 2013-10-23 张佳奇 Medicament for treating mastitis, and preparation method thereof
CN103386091A (en) * 2013-08-05 2013-11-13 李竞 Rupikang traditional Chinese medicine composition and capsule preparation method
CN103720930A (en) * 2013-11-15 2014-04-16 北安市飞龙动物药厂 Traditional Chinese medicine composition for treating dairy cow mastitis
CN103751429A (en) * 2013-11-15 2014-04-30 北安市飞龙动物药厂 Traditional Chinese medicine composition for treating bovine mastitis
CN103830627A (en) * 2014-02-28 2014-06-04 牛良信 Medicine for treating acute mastitis and preparation method thereof
CN104043022A (en) * 2014-06-25 2014-09-17 汤华淑 Traditional Chinese medicine composition for treating gynecologic inflammation
CN104189777A (en) * 2014-09-22 2014-12-10 齐齐哈尔医学院 Traditional Chinese medicine preparation for treating mastitis
CN105381398A (en) * 2015-11-20 2016-03-09 薛学明 Medicine for treating mastitis and preparation method of medicine

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102670793A (en) * 2012-05-04 2012-09-19 山西华诚睿光生物科技有限公司 Chinese herba preparation for increasing cow immunity and reducing milk somatic number and preparation method
CN102670793B (en) * 2012-05-04 2014-04-30 山西华诚睿光生物科技股份有限公司 Chinese herba preparation for increasing cow immunity and reducing milk somatic number and preparation method
CN102973923B (en) * 2012-12-19 2014-06-18 上海光明荷斯坦牧业有限公司 Compound premix for preventing and treating dairy cow mastitis recessive, and preparation method and application
CN102973923A (en) * 2012-12-19 2013-03-20 上海光明荷斯坦牧业有限公司 Compound premix for preventing and treating dairy cow mastitis recessive, and preparation method and application
CN103041363B (en) * 2013-01-21 2014-04-09 孔云 Medicament for treating mammitis
CN103041363A (en) * 2013-01-21 2013-04-17 孔云 Medicament for treating mammitis
CN103191370B (en) * 2013-04-10 2014-07-23 成都中医药大学 Medicine composite for treating mastitis and preparation method and application of medicine composite
CN103191370A (en) * 2013-04-10 2013-07-10 成都中医药大学 Medicine composite for treating mastitis and preparation method and application of medicine composite
CN103356802A (en) * 2013-07-26 2013-10-23 张佳奇 Medicament for treating mastitis, and preparation method thereof
CN103386091A (en) * 2013-08-05 2013-11-13 李竞 Rupikang traditional Chinese medicine composition and capsule preparation method
CN103720930A (en) * 2013-11-15 2014-04-16 北安市飞龙动物药厂 Traditional Chinese medicine composition for treating dairy cow mastitis
CN103751429A (en) * 2013-11-15 2014-04-30 北安市飞龙动物药厂 Traditional Chinese medicine composition for treating bovine mastitis
CN103720930B (en) * 2013-11-15 2016-07-06 北安市飞龙动物药厂 A kind of Chinese medicine composition treating bovine mastitis
CN103830627A (en) * 2014-02-28 2014-06-04 牛良信 Medicine for treating acute mastitis and preparation method thereof
CN104043022A (en) * 2014-06-25 2014-09-17 汤华淑 Traditional Chinese medicine composition for treating gynecologic inflammation
CN104189777A (en) * 2014-09-22 2014-12-10 齐齐哈尔医学院 Traditional Chinese medicine preparation for treating mastitis
CN105381398A (en) * 2015-11-20 2016-03-09 薛学明 Medicine for treating mastitis and preparation method of medicine

Similar Documents

Publication Publication Date Title
CN101972444A (en) Traditional Chinese medicine composition for treating mastitis and preparation method thereof
CN101766782B (en) Chinese medicine composite for treating chronic gastritis and preparation method thereof
CN101869691B (en) Chinese medicinal composition for treating dysmenorrhea and preparation method thereof
CN101785845B (en) Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment
CN101966320A (en) Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof
CN101757566A (en) Traditional Chinese medicine composition for treating colon cancer and preparation method thereof
CN101711851B (en) Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof
CN101757509B (en) Traditional Chinese medicine composition for treating icterohepatitis and preparation method thereof
CN101785847A (en) Traditional Chinese medicine combination for intestinal caner treatment and preparation method thereof
CN101766789B (en) Chinese medicine composite for treating appendicitis and preparation method thereof
CN101780253B (en) Traditional Chinese medicine compound for treating intestinal abscess and preparation method thereof
CN101773634A (en) Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof
CN101972432B (en) Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof
CN101773632B (en) Chinese medicine composition for treating dizziness and preparation method thereof
CN101966321A (en) Traditional Chinese medicinal composition for treating breast cancer and preparation method thereof
CN101966319A (en) Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof
CN101837112B (en) Chinese medicinal composition for curing irregular menstrual period and preparation method thereof
CN101966318A (en) Traditional Chinese medicinal composition for curing breast pain during menstruation and preparation method thereof
CN101816772B (en) Chinese medicament for treating globus hystericuss and preparation method thereof
CN101966289A (en) Chinese medicinal composition for treating frigidity and preparation method thereof
CN101773649A (en) Chinese medicine composition for treating acute abdomen and preparation method thereof
CN101829315B (en) Traditional Chinese medicine composition for treating headache during menstruation and preparation method thereof
CN101757602B (en) Traditional Chinese medicine composition for treating cardiac carcinoma and preparation method thereof
CN102008680B (en) Traditional Chinese medicine composition for treating abdominal mass and myoma and preparation method thereof
CN101773647B (en) Chinese medicine composition for treating duodenal carcinoma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20110216